Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Fernanda de Freitas Anibal

Fernanda de Freitas Anibal

University of São Paulo Brazil

Eugenie Bergogne-Berezin

Eugenie Bergogne-Berezin

Paris University France

Zharov Vladimir P

Zharov Vladimir P

University of Arkansas for Medical Sciences USA

Michael T. Brady

Michael T. Brady

Nationwide Children’s Hospital USA

Paul Julius Caesar

Paul Julius Caesar

University Medical Center Groningen Netherlands

Lia Monica Junie

Lia Monica Junie

University of Medicine and Pharmacy Romania

Pietro Mastroeni

Pietro Mastroeni

University of Cambridge UK

Soza Tharwat Mohammed Baban

Soza Tharwat Mohammed Baban

University of Nottingham UK

Infection Control 2025

Infection Control 2025

About Infection Control 2025 Conferences in Italy:

Conference Series LLC Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USAEurope & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.With the grand success from the previous relevant annual International conferences, ConferenceSeries Llc Ltd is organizing "9th International Conference on Infectious Diseases: Control and Prevention" (Infection Control 2025) scheduled during January 30-31, 2025 in London, UK. Infection Control 2025 brings together the global leaders in infection control and relevant fields to present their research at this exclusive scientific program.

Details of Infection Control 2025 Conferences in Italy:

Conference Name



Infection Control 2025

London, UK

January 30-31, 2025


The Infection Control 2025 conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. Infection control 2024 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific researches in oral and poster sessions.

Infection control is required to prevent the transmission of communicable diseases in all health care settings. Infection control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. the risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CRE, CDI, MRSA, SSI, etc.) and the type of patient-care activity or procedure being performed and the underlying patient's host defences.

When we look at the worldwide deaths due to Infectious Diseases the conference get significance on some diseases like Tetanus (500,000), measles (1 million), Malaria (2.1million), hepatitis b (1.1million), diarrhoea (3.1 million), tuberculosis (3.1 million), HIV/AIDS (1 million) and respiratory Infections (4.4 million).

Who should attend?

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologists
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Health Care Professionals
  • Infectious Diseases Specialists
  • Infection Prevention and Infection Control Specialists

Why to attend

With members from all over the world concentrated on learning about global trends on emerging infectious diseases and it promotes in therapeutic and diagnostic market, this is your finest chance to reach the largest accumulation of participants from the Infectious diseases community. This particular conference Infection Control conduct presentations, distributes information, conducts meetings with current and prospective scientists, make a splash with new drug developments, and receive name recollection at this 2 days event. World distinguished speakers, the most recent therapeutic and diagnostic techniques, developments of Novel technologies and therapeutic measures for infectious diseases prevention and treatment are the authentication marks of this conference.

Targeted Audience

  • Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
  • Infectious Diseases Researchers, Scientists, Faculties, Students
  • Infectious Diseases Associations and Societies
  • Medical Colleges
  • Pharmaceutical Companies and Industries
  • Medical Devices Manufacturing Companies
  • Drug Manufacturing Companies and Industries
  • Laboratory Technicians and Diagnostic Companies
  • Business Entrepreneurs and Industrialists
  • Training Institutes
  • Software Developing Companies
  • Data Management Companies

Young Research Forum-Young Scientist Benefits

Young Research’s Awards at Infection Control 2025 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation.

Young Scientist Benefits

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

For Scientific Sessions please go through the link:

For Abstract Submission please go through the link:



Session & Track

Session-1:  Infectious Disease Pathology

Plant pathology (likewise phytopathology) is the logical investigation of sicknesses in plants caused by pathogens (irresistible creatures) and ecological conditions (physiological factors).Organisms that reason irresistible malady incorporate growths, oomycetes, microorganisms, infections, viroids, infection like life forms, phytoplasmas, protozoa, nematodes and parasitic plants. Excluded are ectoparasites like bugs, vertebrate, or different nuisances that influence plant wellbeing by utilization of plant tissues. Plant pathology additionally includes the investigation of pathogen recognizable proof, sickness etiology, ailment cycles, monetary effect, plant malady the study of disease transmission, plant ailment protection.

Session-2: Infection Treatment and Control

Contamination counteractive action and control is required to keep the transmission of Infectious Ailments in all social insurance frameworks. These maladies are typically caused by microscopic organisms or infections and can be spread by human to human contact, creature to human contact, human contact with a contaminated surface, airborne transmission through little beads of irresistible operators suspended noticeable all around lastly, by such regular vehicles as water or sustenance. Infection control and Counteractive action requests a fundamental comprehension of the study of disease transmission of maladies, chance factors that expansion quiet defencelessness to contamination, and the practices, methodology and medicines that may bring about diseases. Late systems have demonstrated that there is no illness that can't be dealt with.

Session-3: Emerging Infectious Diseases

An Infectious malady whose event has expanded in the previous years or a reason to increment is named as developing. These maladies incorporate new diseases, beforehand unrecognized contaminations and old contaminations returning because of antimicrobial protection, general medical problems and unhygienic conditions. Human irresistible specialists develop and seem assignable to connection of different propelled factors between the host and pathogen each determined by the prerequisite to secure the achievement of the species in dynamical situations. Adjustment by one accomplice to exploit new situations can commonly animate the inverse to change its highlights to require favourable position of the change. Methicillin-ResistantStaphylococcus aureus, Atomic Epidemiology, New or Rapid Diagnostics, Testing/Quality Assurance, Host and Microbial Genetics, Antibody Preventable Diseases, New Vaccines.

Session-4: Influenza and Diagnostic Approaches

Early diagnosis of influenza viral infections are critical for rapid initiation of antiviral therapy to reduce influenza related morbidity and mortality both during seasonal epidemics and pandemics. Several different approaches are currently available for diagnosis of influenza infections in humans. These include viral isolation in cell culture, immunofluorescence assays, nucleic acid amplification tests, immune chromatography-based rapid diagnostic tests, etc. Newer diagnostic approaches are being developed to overcome the limitations associated with some of the conventional detection methods. The rapid flu swab test is a relatively fast and accurate method for diagnosing influenza.

Session-5: Vaccine Research & Development

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Session-6: Veterinary Infection Control

Infectious diseases of animals are a major hazard to earthly animal health and welfare and their effective control is necessary for agronomic health, for defending and procuring national and international food supplies and for mitigating rural poverty in developing countries. Some catastrophic livestock diseases are regional in many parts of the world and threats from old and new pathogens continue to rise, with changes to worldwide climate, agricultural approaches and anthropology presenting conditions that are especially supportive for the spread of arthropod-borne diseases into new geographical fields. Zoonotic or phonetic infections that are transmissible either directly or indirectly between animals and humans are on the increase and pose serious additional risks to human health and the recent pandemic status of new influenza A (H1N1) is a topical illustration of the challenge presented by zoonotic viruses. Veterinary scientists often collaborate with Epidemiologists.

Session-7: HIV Prevention, Treatment and Cure

HIV/AIDS still remains one of the most critical health challenges in the face of the world. According to reports around 36.7 million people are living with HIV and an estimated 1.8 million new infections are recorded in year 2016. There are some certain ways through which HIV can spread from one person to another such as blood, semen, pre-seminal fluids, rectal fluids, vaginal fluids and breast milk. HIV transmission is only possible if these fluids come in contact with the mucous membrane or damaged tissue or are directly injected into the bloodstream. HIV can also transmit from a mother to her child during the time of pregnancy, childbirth or breastfeeding. Earlier, there were some cases of HIV transmission during organ or tissue transplant from a HIV infected person. HIV treatment involves taking medicines that are called antiretrovirals also known as ARV. These are always given in combination with other antiretrovirals. The therapy involved is called antiretroviral therapy also named as ART. Using ART drugs has significantly reduced the number of deaths related to AIDS.

Session-8:  Nosocomial Infections & Control

These infections are acquired due to development of favourable conditions in hospital environment, infected by a patient during a hospital visit or one developing among hospital staff. The types of microorganisms cause nosocomial infections contribute about 99,000 deaths each year according to Centers for Disease Control and Prevention. Recent survey by hospitals reports, Gram-negative infections are estimated to account for two-thirds of the 25,000 deaths each year. Urinary tract infections, pneumonia, bloodstream, and other parts of the body are comes under these category. Most of the infections are difficult to attack with antibiotics, and Gram-negative bacteria resistant to antibiotic can infect people outside the hospital. The prevention and control of nosocomial infections sets new goals for the epidemiologists and infection control practitioners beyond the basics. 

Session-9:  Pediatric Infectious Diseases

Pediatrics is the field of medicine that is concerned about the well-being of neonatal, children, and adults. It also concerns on their development and advancement and their chance to accomplish maximum capacity as grown-ups. The Pediatric academy of America, prescribes that the children should be under pediatric care, up to the age of 21. The point of investigation of pediatrics is to decline the death rate of children and newborns, to control the spread of infectious diseases, for a long ailment free life.  Infectious diseases, which annually claim about 14 million lives i.e. 25% of the more or less 56 million deaths recorded worldwide. The recent trends of pediatrics have achieved exceptional advances in reductions in childhood mortality. The global challenge of preventing HBV in children has shown that the deadliest infectious diseases can be prevented by acquiring proper awareness.

Session-10: Disinfection and Sterilization

Disinfection and Sterilization are the most common decontamination process, where the disinfection is used to eliminate or reduces the harmful pathogens from the objects or surfaces, and sterilization is process of killing the microbes, spores and harmful pathogens. Disinfectant types includes, air disinfectants, alcohols, aldehydes, oxidizing agents, and phenolic are used to decontaminate the surfaces and, sterilizations types includes steam, heat, chemical sterilization, radiation sterilization, and sterile filtration are used for food, medicine and surgical instruments. Most of adherence to strict recommendation of these methods can reduce the infections associated with contaminated items of patients or food processing. 

Session-11:  Nursing Infection Control

Contamination control nurture is a medical caretaker that spends significant time in keeping the spread of irresistible specialists, for example, infections and microscopic organisms. As contamination control nurture, you will take part in counteracting risky flare-ups and pestilences. Contamination control medical attendants ought to show a great tender loving care and powerful relational abilities. They will frequently need to perform obligations, for example, showing others how to avert and contain episodes and plagues and also work with government organizations to contain these occurrences. The essential obligation of contamination control medical attendants is to keep the spread of irresistible operators. To do this, these attendants will frequently need to teach other therapeutic experts and regular citizens on contamination aversion procedures. This may incorporate advising others about how certain irresistible specialist spread, alongside how to shield themselves as well as other people from defilement.

Session-12:  Risk Factors & Prevention

The patient risk factors depend on the direct relationship between the age and susceptibility towards infections.  Mostly these factors can be seen due to impaired immune function, anatomic, functional changes, and amount of exposure towards infection results in the elder patients reduces the quality of life during the infection and conditions are fatal. The range of serious risk factors commonly seen in elder patients with respiratory infections, hospital acquired infections or nosocomial infections, also the other factors particular cited in the patients with urinary tract infections, hepatitis and salmonellosis.

Session-13:  Infection Control Bacteriology

Bacteriology and Infectious Diseases rely upon examination of Bacterial Ecology, Bacterial Infection, Pathogenic Bacteria, Bacterial toxins, Bacterial genomics, Salmonella, Bacterial Diseases, immunology, bacteriology, mycology, virology, parasitology, Parasitic Worms, Anthrax, Biological weapons, Leprosy, pathology, and pathophysiology of the causative specialists of infectious diseases. It likewise serve to give bits of knowledge into until now unexplored domains of clinical microbiology and infectious diseases, for example, improvement of multi-medicate protection (MDR), advancement of novel antibodies and anti-toxins to neutralize the impacts of MDR, variety of contamination and illness dissemination mapping. It also provides novel discoveries on the ecology, biochemistry and genetics of pathogenic bacteria, viruses, fungus and other infectious parasites. Contemporary findings pertaining to the development of highly advanced diagnostic and therapeutic methods against infectious diseases viz. malaria, influenza, tuberculosis, leprosy, whooping cough, polio, Hepatitis-A, HIV/AIDS.

Session-14:  Infection Control in Dental

Dentistry touches every part of our lives, however, is usually underestimated. Your mouth is a window to the strength of your body. It can lead to deficiencies or general oral diseases. Despite whether you are 80 or 8, your oral prosperity is important. Diseases that affect the entire body, may first start up normally and will be unnoticed because of mouth wounds or other oral issues. Presently patients can make use of the advances in  Clinical dentistry and dental practices can benefit by the opportunity to propel  their business a forward way. Infections in oral health care settings can be controlled by following the procedures and precautions are taken to prevent spreading of infectious diseases.  According to the Centers for Disease Control and Prevention, special recommendations need to be followed in dental offices including, cleaned and decontaminated surfaces, cleaned and sterilized dental items must be used in between patients, usage of appropriate protective garb (gloves, gowns, masks, and eyewear) and, most of the transmission of infectious diseases such hepatitis B, hepatitis C, and HIV can be controlled in the dental offices.

Session-15:  Practices & Awareness

Public awareness refers to the important role that community knowledge and enthusiasm has in building manageable societies. Delivering knowledge to remote communities requires strategies for effective communication regarding infections treatment and control and maintenance of good hygienic conditions by creating healthy environment and infection free world. The growing aging population, with associated rise in the incidence of chronic diseases have also led to an increased demand of infection control products. However, factors such as stringent regulatory requirements and the need to comply with them may restrain the growth of infection control market to a certain extent.

Session-16:  Hepatitis Prevention

The greater part as a relatable point routes from claiming transmission for hepatitis infections are blood transfusions also blood results utilizing unscreened blood (in the vast majority created nations blood need been screened since regarding 1990). Medicinal or dental intercessions without sufficient disinfection for supplies. Mothball will, hepatitis C). Needle stick harm done social insurance settings. Imparting gear for injecting baby throughout labour (very basic for hepatitis B; Lesquerella as a relatable point previously pills. Offering razors, toothbrushes alternately other family articles. Tattooing also muscle to piercing if finished utilizing unsterilized supplies. On account from claiming hepatitis B, contamination camwood also happen through hosting unprotected sex for a contaminated man. Though you believe you might need been toward danger starting with possibly hepatitis B or C, it may be essential on get tried. A particular test may be needed to every.

Session-17:  Infection Control Precautions

Infection control precautions are a set of standard recommendations for designed to reduce the risk of transmission of infectious agents from body fluids or environmental surfaces that contain infectious agents. Infection prevention and control uses a risk management approach to minimise or prevent the transmission of infection. The two-tiered approach of standard and transmission-based precautions provides a high level of protection to patients, healthcare workers and other people in healthcare settings. The use of standard precautions aims to minimise, and where possible, eliminate the risk of transmission of infection, particularly those caused by blood borne viruses.

Session-18:  Treatment for Tuberculosis

Tuberculosis is a bacterial infection caused by a bacterium called mycobacterium tuberculosis which spread through the lymph nodes and blood stream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine and brain. Tuberculosis is a deadly infectious disease caused by mycobacterium tuberculosis and it is transmitted through air via droplets through cough and sneeze. Most of the infections do not have symptoms and this condition is called as latent tuberculosis which should be treated immediately otherwise it leads to death. Tuberculosis mainly affects lungs and other parts of the body as well.

Session-19:  Infection Control Treatment & Diagnosis

Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated. Medical diagnosis is the process of determining which disease or condition explains a person's symptoms and signs. Laboratory tests may identify organisms directly (e.g., visually, using a microscope growing the organism in culture) or indirectly (e.g., identifying antibodies to the organism). General types of tests include microscopy, culture and immunologic tests (agglutination tests such as latex agglutination, enzyme immunoassays, western blot, precipitation tests and complement fixation tests) and nucleic acid/ non nucleic acid based identification methods. Sub types of diagnoses include clinical, laboratory, radiology, principal and admitting diagnosis. Advanced methods have been implemented to diagnose the infection in any part of the body. Examples include biomarkers/ elisa test/ chest x ray/ skin biopsy/ tympanometry and tympanocentesis.

Session-20: Infection Control Business

Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.

Session-21: Practical Guidelines

One of the prime effective ways in which we've got to protect ourselves from ill health is  personal hygiene. This suggests wash your hands especially, however additionally your body. It means that being careful to not cough or sneeze on others, cleansing things that you simply bit if you're unwell, golf stroke things like tissues into a bin, associate degree victimisation protection after you may be in danger of catching an infection. People should know about guidelines and recommendations related to infection prevention. HAIs are currently one of the top ten leading causes of death in the United States. Healthcare professionals have an important role in HAI prevention. Infection control measures are a set of standard recommendations that can be used to reduce the risk of transmission of infectious agents from body fluids that contain infectious agents.

Session-22: Covid-19 Infections

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19 and become seriously ill or die at any age. The best way to prevent and slow down transmission is to be well informed about the disease and how the virus spreads. Protect yourself and others from infection by staying at least 1 metre apart from others, wearing a properly fitted mask, and washing your hands or using an alcohol-based rub frequently.

Related Societies                

USA: AIDS Healthcare Foundation, Centre for AIDS Research, Northland Cares, Arizona, The McGregor Clinic, Inc., Canadian Public Health Association, Tropical Pathology & Infectious Diseases Associations, International Society for Infectious Diseases, AIDS United,, AmfAR, UNAIDS, The Elizabeth Taylor AIDS Foundation, International AIDS Society, International HIV/AIDS Alliance, Addiction Research and Treatment Corporation, AIDS Community Research Initiative of America, Albert Einstein College of Medicine, Community Healthcare Network, Elmhurst Hospital Center, Evergreen AIDS Foundation, Lifelong AIDS Alliance

EuropeEuropean Society for Clinical Microbiology and Infectious Diseases,  British Society for Antimicrobial ChemotherapySociety for General Microbiology

Asia PacificHuman Genetics Society of AustralasiaGenetics Society of JapanNDC Medicine.

Market Analysis

Importance and Scope

The worldwide Infectious disease diagnostics market was estimated at USD 13.93 Billion in 2016 and predicted to achieve USD 19.35 Billion in 2023, at a CAGR of 5.6%. The base year is taken into account for the analysis is 2016, and the prediction for the market size is offered for the interval between 2018 and 2023. Expansion in this market is principally constrained by the growing global occurrence of Infectious diseases, shift in focus from integrated research laboratory to decentralized point-of-care testing, and development in funding for investigation on Infectious disease diagnostics.

Increasing prevalence of target diseases, increasing health consciousness among people, and elevated demand for self-care medical devices are anticipated to promote the expansion of the market through the forecast period. Moreover, establishment of novel products with improved sensitivity, speed, and user-friendliness is estimated to augment the adoption of Invitro Diagnostic tests for infectious diseases over the coming years.

Technological improvements such as convenient Real Time Polymerase Chain Reaction (qPCR) and expanding market penetration of technologies such as self-testing devices are key drivers in this therapeutic area. However, presence of uncertain regulatory framework and high price of Invitro Diagnostic tests are inhibiting the progress of the market.

Expanding worldwide prevalence of Infectious diseases

The overall existence of infectious diseases such as influenza, HPV, hepatitis, HIV, and tuberculosis is remarkably high in spite of substantial advances in public health practices and medicine. Many of the presently available analytical practices are slow, include complex procedures, and deficient in specific detection of causative microbial agents. Due to this, patients are obtaining empiric, wide-spectrum antimicrobial therapy as an alternative of appropriate therapies. This caused the improvement of super-resistant microbes.

Growing awareness about personalized medicine

Expanding awareness in patients about the enhancements of personalized medicine is one of the vital considerations resulting in the enhanced use of molecular diagnostics and genomics & proteomics knowledges in infectious disease testing. Diagnostic tests can be applied to evaluate the effectiveness of certain therapeutic agents in specific patients. With the assistance of diagnostic tests, patients who undergo disproportionately severe harmful effects from a given medication or dosage can be detected. Moreover, analytic tests help in deciding the optimal dosages for drugs whose therapeutic effects are known to vary widely among different patient groups. The extent or progression of a disease and preventive actions can be detected in patients through diagnostic assessments. With the rising demand for personalized medicine, the requirement for such diagnostic tests is projected to increase worldwide.

One of the most broadly used customized treatment regimens contains therapeutic drug monitoring tests to choose drugs for resistant HIV strains. The increasing availability of genetic and molecular diagnostic tests performs a crucial role in empowering the initial discovery of infections and offering more personalized medications; this can potentially result in substantial savings in medication costs.

Research Methodology

The research report validates the size of the global Infectious disease diagnostics market and assess the size of several other related submarkets. Most Important players in the market were recognized through secondary study and their market presence was analysed through primary and secondary research.

Applications Perceptions

In-Vitro Diagnostics (IVD) devices are employed in testing and diagnosis of numerous infectious diseases, such as HIV, Methicillin-resistant Staphylococcus aureus (MRSA), streptococcal infections, influenza, and hepatitis. HIV diagnostic assessments carried the largest share in the IVD infectious diseases market in 2018. The part is primarily driven by high disease burden, low consumer awareness, and unmet clinical needs in developing countries.

Key players are revising range of test menus for their qPCR instruments by undertaking R&D initiatives for advancement of kits to curb evolving diseases or by arriving into agreements with other kit manufacturing companies.

Past Conference Report

Infection Control 2024

The 8th International Conference on Infectious Diseases: Control and Prevention (Infection Control 2024) hosted by Conference Series LLC Ltd during May 16-17, 2024, Rome, Italy. It was organized by Conference Series LLC Ltd and generous response was received from the Editorial Board Members of our Supporting Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2024 from Conference Series LLC Ltd.

The program witnessed thought provoking keynote and plenary presentations from experts in the field of Infectious Diseases, Control Prevention highlighting the theme, “Implementing Innovative Methods in Infection Prevention and Control”.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Infectious Disease Pathology
  • Infection Treatment and Control
  • Emerging Infectious Diseases
  • Influenza and Diagnostic Approaches
  • Vaccine Research & Development
  • Veterinary Infection Control
  • HIV Prevention, Treatment and Cure
  • Nosocomial Infections & Control
  • Pediatric Infectious Diseases
  • Disinfection and Sterilization
  • Nursing Infection Control
  • Risk Factors & Prevention
  • Infection Control Bacteriology
  • Infection Control in Dental
  • Practices & Awareness
  • Hepatitis Prevention
  • Infection Control Precautions
  • Treatment for Tuberculosis
  • Infection Control Treatment & Diagnosis
  • Infection Control Business
  • Practical Guidelines

We would like to acknowledge our sincere thanks and support to our honourable organizing committee members

Infection Control 2024 played an important role in promoting multidisciplinary interactions between Infectious Diseases and Control Prevention to enhance research in HIV Prevention. The program covered current and emerging research innovations in the field of Infectious Diseases.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of infectious diseases. The eminent personalities at the conference were

Keynote Speakers:

Dong H. Kwon, Long Island University, USA

Paul J Caesar, PENTAX Medical EMEA, Germany

Session Speakers:

Michael Mark Dalauidao, King’s College Hospital NHS Foundation Trust, UK

Chatuphon Phuwongsa, Bankruat Hospital, Thailand

Luis Martin Moltrasio, Instituto Cordis, Argentina

Fuxiang Wang, Shenzhen Third People's Hospital, China

Ogra Marufu, Sidra Medicine, Qatar

Jibi Thankachan, Tertiary Care Hospital, UK

Radhika Krishnan Radhakrishnan, Primary Health Care Corporation, Qatar

Amani Hashim Yousif , Kau Midical Servec Center, Saudi Arabia

Yogesh Kumar Gupta, Rukmani Birla Hospital, India

Fahad AL Jarboa, King Abdulaziz Medical City, Saudi Arabia

Jessica Dangles, Executive Director at CBIC, USA

Sarafraz Ahmad Kasana, Govt Medical College, India

Poster Presentations:

Huseynov Elchin Mammad, Azerbaijan Medical University, Azerbaijan

Rounaq Rasool, Pacific Medical College & Research, India

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Infection Control 2024 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series LLC Ltd would like to announce the commencement of "9th International Conference on Infectious Diseases: Control and Prevention” January 30-31, 2024 | London, UK

For details, Visit:

Let us meet again @Infection Control 2025 at London UK



Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date January 30-31, 2025

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Epidemiology: Open Access Journal of Infectious Diseases and Therapy Journal of ClinicInfectious Diseases & Practice

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


  • 2019-nCoV
  • Antibiotic Resistance
  • Bacterial Infections
  • Corona Virus
  • Coronaviruses
  • Covid-19 Infections
  • COVID-19 Pregnancy
  • Disinfection And Sterilization
  • Ebola Virus Disease
  • Emerging Infectious Diseases
  • Hendra Virus
  • Hepatitis
  • Hepatitis Prevention
  • HIV Infection
  • HIV Prevention, Treatment And Cure
  • Human Herpesvirus
  • Immunizations
  • Infection Control Bacteriology
  • Infection Control Business
  • Infection Control In Dental
  • Infection Control Precautions
  • Infection Control Treatment & Diagnosis
  • Infection Treatment And Control
  • Infectious And Non-infectious Diseases Vaccines
  • Infectious Disease Pathology
  • Infectious Disease Transmission
  • Influenza And Diagnostic Approaches
  • Malaria
  • Mycobacterial Infections
  • Nosocomial Infections & Control
  • Nursing Infection Control
  • Parasitic Infections
  • Pediatric Infectious Diseases
  • Practical Guidelines
  • Practices & Awareness
  • Prion Diseases
  • Public Health And Epidemiology
  • Rare Diseases
  • Risk Factors & Prevention
  • SARS Coronavirus
  • Sexually Transmitted Diseases
  • Tick-borne Diseases
  • Treatment For Tuberculosis
  • Tuberculosis (TB)
  • Vaccine Research & Development
  • Vertical Coronavirus
  • Veterinary Infection Control
  • Viral Infections, Non-HIV
  • Zika Virus